1396
S. Naud, J.-C. Cintrat
PAPER
MS (ESI/TOF): m/z (%) = 446 (M + 1, 100), 388 (M – 57, 11).
(S)-4-Benzyl-3-[1-(tributylstannyl)vinyl]-1,3-oxazolidin-2-one
(12 )
HRMS (FAB): m/z calcd for C16H30NO2Sn [M – Bu]+·, 388.12985;
found, 388.1306.
[ ]D25 19.8 (c = 0.98).
FTIR (NaCl): 1746 cm–1.
(S)-4-Isopropyl-3-[(Z)-1-(tributylstannyl)-2-(trimethylsilyl)vi-
1H NMR: = 0.81–1.70 (m, 27 H, Bu), 2.74 (dd, 1 H, CH2, 3J = 8.5,
nyl]-1,3-oxazolidin-2-one
[(Z)-16 ]
2J = 13.4 Hz), 3.26 (dd, 1 H, CH2, 3J = 2.4, 2J = 13.4), 4.18 (m, 2 H,
3
CH2O), 4.38–4.48 (m, 1 H, CHN), 4.73 [s, 1 H, JSn–H(cis) = 42.1],
[ ]D25 –124.6 (c = 1.21).
5.18 [s, 1H, 3JSn–H(trans) = 95.2, 98.9 Hz], 7.14–7.37 (m, 5 H, Ar).
FTIR (NaCl): 1741 cm–1.
13C NMR: = 12.3 (1JC–Sn = 351.7, 368.7 Hz), 13.9, 27.5
(3JC–Sn = 61.0 Hz), 29.2 (2JC–Sn = 17.1 Hz), 35.8, 55.3, 66.4,
105.3 (2JC–Sn = 34.2 Hz), 127.3, 129.0, 129.4, 135.9, 145.9
(1JC–Sn = 339.4, 354.0 Hz), 156.7.
HRMS (FAB): m/z calcd for C20H30NO2Sn [M – Bu]+·, 436.12985;
found, 436.131.
1H NMR: = 0.14 (s, 9 H, Me3Si), 0.72–1.62 (m, 33 H, Bu, CH3),
4
3
2.20–2.36 (m, 1 H, CH), 4.09 (ddd, 1 H, CHO, J = 0.6, J = 7.3,
2J = 8.5 Hz), 4.24 (td, 1 H, CHO, 4J = 0.6, 3J = 8.5 Hz), 4.32–4.42
(m, 1 H, CHN), 5.69 (s, 1 H, 3JSn–H = 117.8, 123.3 Hz).
13C NMR: = 0.9 (1JC–Si = 53.7 Hz), 13.7 (1JC–Sn = 341.8, 356.5
Hz), 14.6, 18.2, 25.9, 27.7 (3JC–Sn = 65.9 Hz), 29.2, 58.1, 63.1, 126.7
(2JC–Sn = 107.4 Hz), 155.7 (1JC–Sn = 385.7, 405.3 Hz), 157.0.
(S)-4-Benzyl-3-[(Z)-1-(tributylstannyl)-2-(trimethylsilyl)vinyl]-
1,3-oxazolidin-2-one [(Z)-13 ]
MS (ESI/TOF): m/z (%) = 540 (M + 23, 79), 460 (M – 57, 100).
HRMS (FAB): m/z calcd for C19H38NO2SiSn [M – Bu]+·,
460.16938; found, 460.17.
[ ]D25 –97.4 (c = 2.1).
FTIR (NaCl): 1629cm–1.
1H NMR: = 0.20 (s, 9 H, Me3Si), 0.80–1.65 (m, 27 H, Bu), 2.61
(dd, 1 H, CH2, 3J = 9.1, 2J = 14.0 Hz), 3.29 (dd, 1 H, CH2, 3J = 3.1,
2J = 14.0 Hz), 4.10 (dd, 1 H, CHO, 3J = 6.1, 2J = 8.5) Hz, 4.24 (t, 1
H, CHO, 3J = 8.5, 2J = 8.5 Hz), 4.51–4.65 (m, 1 H, CHN), 5.87 (s,
1 H, 3JSn–H = 116.0, 120.9 Hz), 7.06–7.37 (m, 5 H, Ar).
13C NMR: = 1.0 (1JC–Si = 51.3 Hz), 13.8 (1JC–Sn = 341.8, 358.9
Hz), 13.9, 27.7 (3JC-Sn = 65.9 Hz), 29.3, 37.3, 55.3, 67.2,
127.2 (2JC–Sn = 65.9 Hz), 127.3, 129.1, 129.3, 136.1, 156.0
(1JC-Sn = 378.4, 395.5 Hz), 156.6.
(S)-4-Isopropyl-3-[(Z)-bis(trimethylstannyl)vinyl]-1,3-oxazoli-
din-2-one (17)
[ ]D25 –63.0 (c = 1.24).
FTIR (NaCl): 1735cm–1.
2
1H NMR: = 0.20 (s, 9 H, JSn–H = 52.5, 54.9 Hz), 0.21(s, 9 H,
3
2JSn–H = 53.1, 55.5 Hz), 0.79 (d, 3 H, J = 6.1 Hz), 0.87 (d, 3 H,
3J = 6.7 Hz), 2.28–2.41 (m, 1 H), 4.08–4.30 (m, 2 H, CH2O), 4.35–
3
2
4.45 (m, 1 H, CHN), 5.86 (s, 1 H, JSn–H = 43.3, JSn–H = 137.3,
MS (ESI/TOF): m/z (%) = 588 (M + 23, 100), 508 (M –57, 64).
144.1 Hz).
HRMS (FAB): m/z calcd for C23H38NO2SiSn [M – Bu]+·,
508.16938; found, 508.1688.
13C NMR: = –6.7 (1JC–Sn = 341.8, 356.4), –4.3 (1JC–Sn = 361.3,
376.0 Hz), 14.1, 17.9, 25.4, 57.3, 62.9, 124.3 (1JC–Sn = 473.6, 495.6,
2JC–Sn = 80.6 Hz), 154.8, 156.7.
(S)-4-Benzyl-3-[(Z)-bis(tributylstannyl)vinyl]-1,3-oxazolidin-2-
HRMS (FAB): m/z calcd for C13H26NO2Sn2 [M – Me.]+, 468.00075;
found, 468.0007.
one (14)
[ ]D25 –75.0 (c = 1.31).
FTIR (NaCl): 1744 cm–1.
-Stannyl Enamides Transmetallation/Trapping Experiments
A flame dried Schlenk tube is charged with the stannyl compound
(0.3 mmol), placed under vacuum and then under nitrogen. Anhyd
THF is added and the solution is cooled to –100 °C, and n-BuLi (2.4
equiv, 1.6 M/hexane, 0.72 mmol, 450 L) is slowly added at –
100 °C. The solution is stirred for 5 min and the electrophile (2.5
equiv, 0.75 mmol) is added (as a THF solution for ketones). Com-
pletion of the reaction is checked by TLC, H2O (2 mL) is added and
the cooling bath is removed and stirring is continued for 30 min.
The resulting mixture is diluted with THF (50 mL), dried over
Na2SO4, filtered and reduced in vacuo to a residue that was purified
by flash chromatography over silica gel.
1H NMR: = 0.82–1.72 (m, 54 H, Bu), 2.58 (dd, 1 H, CH2, 3J = 9.7,
2J = 13.4 Hz), 3.32 (dd, 1 H, CH2, 3J = 3.1, 2J = 13.4 Hz), 4.14 (dd,
1 H, CHO, 3J = 4.9, 2J = 8.5 Hz), 4.21 (t, 1 H, CHO, J = 8.5 Hz),
3
4.52–4.66 (m, 1 H, CHN), 6.03 (s, 1 H, 2JSn–H = 33.0, 3JSn–H = 124.5,
130.0 Hz), 7.14–7.42 (m, 5 H, Ar).
13C NMR: = 12.0 (1JC–Sn = 334.7, 349.1 Hz), 13.3 (1JC–Sn = 341.8,
361.3 Hz), 13.8, 13.9, 27.5 (3JC–Sn = 58.6 Hz), 27.7 (3JC–Sn = 65.9
Hz), 29.3, 29.4, 36.8, 55.2, 66.9, 123.7 (1JC–Sn = 400.4, 417.5,
2JC–Sn = 73.2 Hz), 127.3, 129.1, 129.2, 136.3, 155.0 (1JC–Sn = 417.5,
437.0, 2JC–Sn = 80.6 Hz), 156.3
HRMS (FAB): m/z calcd for C32H56NO2Sn2 [M – Bu]+·, 726.2355;
found, 726.2351.
3-[1-(1-Hydroxyhexyl)vinyl]-1,3-oxazolidin-2-one (19)
FTIR (NaCl): 3434 (br), 1747, 1620 cm–1.
1H NMR: = 0.77–0.97 (m, 3 H), 1.18–1.88 (m, 8 H), 2.30 (br s, 1
H, OH), 3.50–3.65 (m, 2 H, CH2O), 3.77–3.87 (m, 2 H, CH2N), 4.04
(dd, 1 H, 2J = 3.1, 4J = 1.8 Hz), 4.23 (dd, 1 H, 2J = 3.1, 4J = 2.4 Hz),
4.95–5.05 (m, 1 H).
(S)-4-Isopropyl-3-[1-(tributylstannyl)vinyl]-1,3-oxazolidin-2-
one (15 )
[ ]D25 –2.9 (c = 1.09).
FTIR (NaCl): 1743 cm–1.
13C NMR: = 13.9, 22.4, 23.5, 31.3, 35.3, 43.9, 59.3, 78.8, 80.5,
145.6, 157.4.
1H NMR: = 0.74–1.62 (m, 33 H, Bu, CH3), 2.40–2.56 (m, 1 H,
CH), 4.20 (m, 3 H, CHN, CH2O), 4.58 [s, 1 H, 3JSn–H(cis) = 42.7 Hz],
4.95 [s, 1 H, 3JSn–H(trans) = 96.4, 100.7 Hz).
MS (ESI/TOF): m/z (%) = 214 (M + 1).
13C NMR: = 12.4 (1JC–Sn = 351.6, 368.7 Hz), 13.9, 13.9, 25.3, 27.5
(3JC–Sn = 61.0 Hz), 29.2 (2JC–Sn = 19.5 Hz), 58.7, 62.8, 105.4
(2JC–Sn = 34.2 Hz), 145.7 (1JC–Sn = 346.7, 366.2 Hz), 157.1.
HRMS (EI): m/z calcd for C11H19NO3 [M]+., 213.13649; found,
213.13714.
Synthesis 2003, No. 9, 1391–1397 ISSN 1234-567-89 © Thieme Stuttgart · New York